Oxidized LDL in carotid plaques and plasma associates with plaque instability

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 10, 2002, Pages 1649-1654

  Nishi, Kyoko ^a   Itabe, Hiroyuki ^b   Uno, Masaaki ^a   Kitazato, Keiko T ^a   Horiguchi, Hidehisa ^a   Shinno, Kiyohito ^a   Nagahiro, Shinji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Carotid endarterectomy; Histopathology; Oxidized LDL; Plaque; Plasma

Indexed keywords

APOLIPOPROTEIN B; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OXIDATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RISK FACTORS; TUNICA INTIMA;

EID: 0036791482     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000033829.14012.18     Document Type: Article

References (22)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Steinberg D, Lewis A. Conner memorial lecture: oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062-1071.
3. Parthasarathy S, Santanam N, Ramachandran S, Meilhac O. Potential role of oxidized lipids and lipoproteins in antioxidant defense. Free Radic Res. 2000:33:197-215.
4. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis, basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995:91:2488-2496.
5. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res. 1996;37:45-53.
6. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaka T, Takano T. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions: complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem. 1994;269:15274-15279.
7. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J. Shimamura K, Kimura J, Michishita I, Nagai R. Circulating oxidized modified low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol. 2000;20:2243-2247.
8. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otuska M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Oxidized low density lipoprotein relates to plaque destabilization in human coronary atherosclerotic lesions. Circulation. 2001;103:1955-1960.
9. Ehara S, Ueda M, Naruko T, Haze K, Matsuo T, Ogami M, Ikura Y, Itabe H, Komatsu R, Yoshiyama M, Takeuchi K, Yoshikawa J. Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases. J Diabetes Complications. 2002:16:60-4.
10. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest. 1996:98:800-814.
11. Ylä-HerttuaIa S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989:1086-1095.
12. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998:98:1487-1494.
13. Nishi K, Uno M, Fukuzawa K, Horiguchi H, Shinno K, Nagahiro S. Clinicopathological significance of lipid peroxidation in carotid plaques. Atherosclerosis. 2002;160:289-296.
14. The Ad Hoc Committee. American Heart Association. Guidelines for carotid endarterectomy. Stroke. 1995:26:188-201.
15. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995:273:1421-1428.
16. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Eng J Med. 1991:325:445-453.
17. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997:17:1859-1867.
18. Itabe H, Suzuki K, Tsukamoto Y, Komatsu R, Ueda M, Mori M, Higashi Y, Takano T. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein. Biochim Biophys Acta. 2000;1485:233-245.
19. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Steinberg D, Witztum JL. Lipoproteins in normal and atherosclerotic aorta. Eur Heart J. 1990;11(suppl E):88-99.
20. Galis ZS, Ghitescu LD, Li Z, Alavi MZ, Moore S. Distribution of endogenous apoprotein B-containing lipoproteins in normal and injured aortas of normocholesterolemic rabbits. Lab Invest. 1992;66:624-638.
21. Hammer A, Kager G, Dohr G, Rabl H, Ghassempur I, Jurgens G. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. Arterioscler Thromb Vasc Biol. 1995;15:704-713.
22. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901-905.